Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Colorectal cancer in Chinese patients: current and emerging treatment options

1 Oct 2014

Abstract excerpt

Colorectal cancer is the second most common cancer in Hong Kong and its incidence is rising in economically developed Chinese cities, including Hong Kong and Shanghai. Several studies conducted in the People's Republic of China have characterized the unique molecular epidemiology of familial colorectal cancer syndromes and molecular biomarkers such as microsatellite instability and genetic mutations (eg, KRAS,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25336973
DOI: 10.2147/ott.s48409

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Colorectal cancer in Chinese patients: current and emerging treatment optionsPMID 25336973Read ↗

Recent advances in personalized colorectal cancer research.Semantic proximity Read ↗

Current topics in colorectal cancer.Semantic proximity Read ↗

Pharmacogenomics in colorectal cancer: The first step for individualized-therapySemantic proximity Read ↗

Mechanisms and Strategies to Overcome Drug Resistance in Colorectal CancerSemantic proximity Read ↗

Clinical research progress on BRAF V600E-mutant advanced colorectal cancer.Semantic proximity Read ↗

Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: The state of the artSemantic proximity Read ↗

Update on Emerging Therapies for Advanced Colorectal Cancer.Semantic proximity Read ↗

Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study.Semantic proximity Read ↗

Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?Semantic proximity Read ↗

Genomic Alterations and Clinical Characterization in Chinese Patients with Metastatic Colorectal Cancer.Semantic proximity Read ↗

Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer.Semantic proximity Read ↗

Establishment and characterization of 18 human colorectal cancer cell lines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.